What is M2i Life Sciences?
M2i Life Sciences is a prominent player in the development and application of advanced biocontrol solutions for both plant and animal sectors. Leveraging proprietary technologies such as micro-encapsulation and unique molecular formulations, the company is dedicated to sustainable practices and responsible sourcing. With a robust global footprint supported by extensive research and development capabilities, M2i Life Sciences offers a diverse portfolio of products and services, fostering collaborations and providing a catalog for direct ordering. The company's commitment to innovation and environmental stewardship has been recognized through numerous industry awards.
How much funding has M2i Life Sciences raised?
M2i Life Sciences has raised a total of $13.5M across 1 funding round:
Private Equity
$13.5M
Private Equity (2017): $13.5M with participation from Idinvest Partners
Key Investors in M2i Life Sciences
Idinvest Partners
Idinvest Partners is a mid-market private equity firm based in Paris, France, specializing in financing and supporting entrepreneurs through various stages of business development.
What's next for M2i Life Sciences?
The recent major strategic investment signals a pivotal growth phase for M2i Life Sciences. This capital is expected to fuel further research and development into novel biocontrol agents, enhance its global market penetration, and potentially expand its technological applications. The company's focus on sustainability and its established R&D infrastructure position it well to capitalize on the increasing demand for eco-friendly solutions in agriculture and animal health, aiming to solidify its leadership in the biocontrol industry.
See full M2i Life Sciences company page
